PharmaNet/i3 'Highly Recommended' in ViE Awards Best CRO Category

PharmaNet/i3 is pleased to announce that the Company has been designated “Highly Recommended” by the voters of the ViE Awards presented at the World Vaccine Congress. This recognition is the result of the Company’s work on studies involving 7700 subjects for a global vaccine study in infants and 3344 subjects in a global vaccine study in elderly populations.

PharmaNet/i3 constantly strives to ensure clients receive top quality service from accomplished and highly capable employees in our organization. The “Highly Recommended” designation, as determined by clients and investigative sites that we work with in vaccine development, is an honor and a tribute to the strength of our staff and organization.